Serum paraoxonase 1 activity is associated with fatty acid composition of high density lipoprotein

Disease Markers

Volumn 35, Issue 4, 2013, Pages 273-280

  Boshtam, Maryam ^a   Emami Razavi, Amirnader ^b   Pourfarzam, Morteza ^c   Ani, Mohsen ^c   Naderi, Gholam Ali ^a   Basati, Gholam ^d   Mansourian, Marjan ^c   Dinani, Narges Jafari ^a   Asgary, Seddigheh ^e   Abdi, Soheila ^f  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDIC ACID; ARYLDIALKYLPHOSPHATASE 1; DIHOMO GAMMA LINOLENIC ACID; HIGH DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; MYRISTIC ACID; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; STEARIC ACID;

ADULT; ARTICLE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GAS CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; ULTRACENTRIFUGATION;

8,11,14-EICOSATRIENOIC ACID; ADULT; ARYLDIALKYLPHOSPHATASE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; STEARIC ACIDS;

EID: 84884962938     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/612035     Document Type: Article

References (28)

1. Draganov D. I., La Du B. N., Pharmacogenetics of paraoxonases: a brief review. Naunyn-Schmiedeberg's Archives of Pharmacology 2004 369 1 78 88 2-s2.0-0742304083 10.1007/s00210-003-0833-1
2. Tward A., Xia Y. R., Wang X. P., Shi Y., Park C., Castellani L. W., Lusis A. J., Shih D. M., Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 2002 106 4 484 490 2-s2.0-0037162376 10.1161/01.CIR.0000023623.87083.4F
3. Costa L. G., Cole T. B., Jarvik G. P., Furlong C. E., Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annual Review of Medicine 2003 54 371 392 2-s2.0-0037639963 10.1146/annurev.med.54.101601.152421
4. Barter P. J., Nicholls S., Rye K., Anantharamaiah G. M., Navab M., Fogelman A. M., Antiinflammatory properties of HDL. Circulation Research 2004 95 8 764 772 2-s2.0-6344253356 10.1161/01.RES.0000146094.59640.13
5. Fridman O., Fuchs A. G., Porcile R., Morales A. V., Gariglio L. O., Paraoxonase: its multiple functions and pharmacological regulation. Archivos de Cardiologia de Mexico 2011 81 3 251 260 2-s2.0-84859533461
6. Valabhji J., McColl A. J., Schachter M., Dhanjil S., Richmond W., Elkeles R. S., High-density lipoprotein composition and paraoxonase activity in type 1 diabetes. Clinical Science 2001 101 6 659 670 2-s2.0-0035208506 10.1042/CS20010111
7. Ferretti G., Bacchetti T., Masciangelo S., Bicchiega V., HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity 2010 18 6 1079 1084 2-s2.0-77952952772 10.1038/oby.2009.338
8. Saeed S. A., Elsharkawy M., Elsaeed K., Fooda O., Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients. Hemodialysis International 2008 12 4 471 479 2-s2.0-53549095722 10.1111/j.1542-4758.2008.00311.x
9. Costa L. G., Vitalone A., Cole T. B., Furlong C. E., Modulation of paraoxonase (PON1) activity. Biochemical Pharmacology 2005 69 4 541 550 2-s2.0-12744267818 10.1016/j.bcp.2004.08.027
10. Sutherland W. H. F., Walker R. J., de Long S. A., van Rij A. M., Phillips V., Walker H. L., Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 5 1340 1347 2-s2.0-0032957848
11. Ferrè N., Camps J., Fernández-Ballart J., Arija V., Murphy M. M., Ceruelo S., Biarnés E., Vilella E., Tous M., Joven J., Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clinical Chemistry 2003 49 9 1491 1497 2-s2.0-0041942563 10.1373/49.9.1491
12. Calabresi L., Villa B., Canavesi M., Sirtori C. R., James R. W., Bernini F., Franceschini G., An ω -3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metabolism 2004 53 2 153 158 2-s2.0-0842349501 10.1016/j.metabol.2003.09.007
13. Ferretti G., Bacchetti T., Effect of dietary lipids on paraoxonase-1 activity and gene expression. Nutrition, Metabolism and Cardiovascular Diseases 2012 22 2 88 94 2-s2.0-84856601287 10.1016/j.numecd.2011.08.011
14. Kudchodkar B. J., Lacko A. G., Dory L., Fungwe T. V., Dietary fat modulates serum paraoxonase 1 activity in rats. Journal of Nutrition 2000 130 10 2427 2433 2-s2.0-0033803134
15. Nguyen S. D., Hung N. D., Cheon-Ho P., Ree K. M., Dai-Eun S., Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1). Biochimica et Biophysica Acta 2009 1790 3 155 160 2-s2.0-60249083427 10.1016/j.bbagen.2008.11.009
16. Nguyen S. D., Sok D. E., Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. Biochemical Journal 2003 375 2 275 285 2-s2.0-0142138852 10.1042/BJ20030663
17. de Roos N. M., Schouten E. G., Scheek L. M., van Tol A., Katan M. B., Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Metabolism 2002 51 12 1534 1537 2-s2.0-0036912596 10.1053/meta.2002.36305
18. Razavi A. E., Pourfarzam M., Ani M., Naderi G. A., The associations between high-density lipoprotein mean particle size and its fatty acid composition. Biomarkers in Medicine 2013 7 2 235 245 10.2217/bmm.12.115
19. Risé P., Eligini S., Ghezzi S., Colli S., Galli C., Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukotrienes and Essential Fatty Acids 2007 76 6 363 369 2-s2.0-34447623915 10.1016/j.plefa.2007.05.003
20. Razavi A. E., Ani M., Pourfarzam M., Naderi G. A., Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity. Journal of Research in Medical Sciences 2012 17 11 1020 1026
21. Bełtowski J., Wójcicka G., Jamroz A., Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003 170 1 21 29 2-s2.0-0042696057 10.1016/S0021-9150(03)00236-3
22. Markwell M. A. K., Haas S. M., Bieber L. L., Tolbert N. E., A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analytical Biochemistry 1978 87 1 206 210 2-s2.0-0018178434
23. Folch J., Lees M., Stanley G. H. S., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
24. Morrison W. R., Smith L. M., Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanols. Journal of Lipid Research 1964 5 600 608 2-s2.0-4243190715
25. Nguyen S. D., Sok D. E., Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. Biochemical Journal 2003 375 2 275 285 2-s2.0-0142138852 10.1042/BJ20030663
26. de Roos N. M., Schouten E. G., Scheek L. M., van Tol A., Katan M. B., Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Metabolism 2002 51 12 1534 1537 2-s2.0-0036912596 10.1053/meta.2002.36305
27. Tomás M., Sentí M., Elosua R., Vila J., Sala J., Masià R., Marrugat J., Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity. European Journal of Pharmacology 2001 432 2-3 121 128 2-s2.0-0035824706 10.1016/S0014-2999(01)01482- 0
28. Wallace A. J., Sutherland W. H. F., Mann J. I., Williams S. M., The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. European Journal of Clinical Nutrition 2001 55 11 951 958 2-s2.0-0034758849 10.1038/sj/ejcn/1601250